TL13-112

• Description :

  TL13-112 is a novel Anaplastic Lymphoma Kinase (ALK) -PROTAC developed through conjugation of LDK378 and the cereblon ligand pomalidomide.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  1002.582

• Molecular Formula :

  C49H60ClN9O10S

• Notes :

  Research use only, not for human use.

• Receptor :

  PROTAC

• CAS Number :

  2229037-19-6